• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

“As Needed” nonvitamin K antagonist oral anticoagulants for infrequent atrial fibrillation episodes following atrial fibrillation ablation guided by diligent pulse monitoring: A feasibility study
ConclusionThe use of as needed NOACs when AF is suspected with pulse monitoring is effective and safe to maintain low risk of stroke and bleeding after successful ablation. Transition back to daily NOAC use should be anticipated in about one quarter of patients.
Source: Journal of Cardiovascular Electrophysiology - February 4, 2019 Category: Cardiology Authors: Erica S. Zado, Monica Pammer, Tara Parham, David Lin, David S. Frankel, Sanjay Dixit, Francis E. Marchlinski Tags: ORIGINAL ARTICLE Source Type: research

“As Needed” Non‐vitamin K Antagonist Oral Anticoagulants for Infrequent Atrial Fibrillation Episodes Following Atrial Fibrillation Ablation Guided by Diligent Pulse Monitoring: A Feasibility Study
ConclusionThe use of as needed NOACs when AF is suspected with pulse monitoring is effective and safe to maintain low risk of stroke and bleeding after successful ablation. Transition back to daily NOAC use should be anticipated in about one quarter of patients.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - February 1, 2019 Category: Cardiology Authors: Erica S Zado, Monica Pammer, Tara Parham, David Lin, David S Frankel, Sanjay Dixit, Francis E Marchlinski Tags: ORIGINAL ARTICLE Source Type: research

Long ‐term risk of stroke and bleeding post–atrial fibrillation ablation
Journal of Cardiovascular Electrophysiology, EarlyView.
Source: Journal of Cardiovascular Electrophysiology - October 12, 2018 Category: Cardiology Authors: Jacqueline Joza, Michelle Samuel, Cynthia A. Jackevicius, Hassan Behlouli, Jing Jia, Maria Koh, Meytal Avgil Tsadok, Anthony S.L. Tang, Atul Verma, Louise Pilote, Vidal Essebag Source Type: research

Long ‐term risk of stroke and bleeding post atrial fibrillation ablation
Journal of Cardiovascular Electrophysiology,Volume 0, Issue ja, -Not available-.
Source: Journal of Cardiovascular Electrophysiology - July 26, 2018 Category: Cardiology Authors: JacquelineJozaMD , MichelleSamuelMPH , Cynthia A.JackeviciusBScPhm, PharmD MSc , HassanBehlouliPhD , JingJiaMSc , MariaKohMSc , Meytal AvgilTsadokPhD , Anthony S.L.TangMD , AtulVermaMD , LouisePiloteMD MPH PhD , VidalEsseb Source Type: research

Anticoagulation use and clinical outcomes after catheter ablation in patients with persistent and longstanding persistent atrial fibrillation
ConclusionAnticoagulation discontinuation in well selected, closely monitored patients following successful ablation of nonparoxysmal AF was associated with a low rate of clinical embolic CVEs. Prospective studies are required to confirm safety of OAT discontinuation after successful AF ablation.This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - February 1, 2018 Category: Cardiology Authors: Jackson J. Liang, Melissa A. Elafros, Michael T. Mullen, Daniele Muser, Tatsuya Hayashi, Andres Enriquez, Rajeev K. Pathak, Erica S. Zado, Pasquale Santangeli, Jeffrey S. Arkles, Robert D. Schaller, Gregory E. Supple, David S. Frankel, Fermin C. Garcia, R Tags: ORIGINAL ARTICLE Source Type: research

Long ‐term aspirin does not lower risk of stroke and increases bleeding risk in low‐risk atrial fibrillation ablation patients
ConclusionsAfter catheter ablation, low risk patients do not benefit from long‐term aspirin therapy, but are at risk for higher rates of bleeding when compared to no therapy or warfarin.
Source: Journal of Cardiovascular Electrophysiology - September 26, 2017 Category: Cardiology Authors: Victoria Jacobs, Heidi T. May, Tami L. Bair, Brian G. Crandall, Michael J. Cutler DO, John D. Day, Charles Mallender, Jeffrey S. Osborn, J. Peter Weiss, T. Jared Bunch Tags: ORIGINAL ARTICLE Source Type: research

Short ‐term outcomes of atrial flutter ablation
ConclusionCardiac etiologies remain the most common reason for the readmission after AFL ablation. Identifying high risk patients, careful discharge planning and close follow‐up post‐discharge can potentially reduce readmission rates in AFL ablation patients.This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - August 11, 2017 Category: Cardiology Authors: Byomesh Tripathi, Shilpkumar Arora, Abhishek Mishra, Vishwa Reddy Kundoor, Sopan Lahewala, Varun Kumar, Mahek Shah, Dhairya Lakhani, Harshil Shah, Nilay V Patel, Nileshkumar J. Patel, Mihir Dave, Abhishek Deshmukh, Sattur Sudhakar, Radha Gopalan Tags: ORIGINAL ARTICLE Source Type: research

Long ‐term aspirin does not lower risk of stroke and increases bleeding risk in low risk atrial fibrillation ablation patients
Conclusions: After catheter ablation, low risk patients do not benefit from long‐term aspirin therapy, but are at risk for higher rates of bleeding when compared to no therapy or warfarin.This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - August 1, 2017 Category: Cardiology Authors: Victoria Jacobs, Heidi T. May, Tami L. Bair, Brian G. Crandall, Michael J. Cutler DO, John D. Day, Charles Mallender, Jeffrey S. Osborn, J. Peter Weiss, T. Jared Bunch Tags: ORIGINAL ARTICLE Source Type: research

Replacing warfarin with a novel oral anticoagulant: Risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study)
ConclusionIn WI patients rechallenged with DOACs, a significant proportion developed repeat MBE. LAAO devices seem reasonable in those patients who undergo major interventions to manage MBE with cautious and temporary continuation of DOAC.
Source: Journal of Cardiovascular Electrophysiology - June 8, 2017 Category: Cardiology Authors: Mohit K. Turagam, Valay Parikh, Muhammad R. Afzal, Rakesh Gopinathannair, Madhav Lavu, Arun Kanmanthareddy, Jayasree Pillarisetti, Madhu Reddy, Donita Atkins, Sudharani Bommana, Melissa Jaeger, Courtney Jeffery, Sanghamitra Mohanty, Pasquale Santangeli, J Tags: ORIGINAL ARTICLE Source Type: research

Replacing warfarin with a novel oral anticoagulant ‐ risk of recurrent bleeding and stroke in patients with warfarin ineligible or failure in patients with atrial fibrillation (The ROAR study)
ConclusionIn WI patients re‐challenged with DOACs, a significant proportion developed repeat MBE. LAAO devices seem reasonable in those patients who undergo major interventions to manage MBE with cautious and temporary continuation of DOAC.This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - April 1, 2017 Category: Cardiology Authors: Mohit K. Turagam, Valay Parikh, Muhammad R. Afzal, Rakesh Gopinnathanair, Madhav Lavu, Arun Kanmanthareddy, Jayasree Pillarisetti, Madhu Reddy, Donita Atkins, Sudharani Bommana, Melissa Jaeger, Courtney Jeffery, Sanghamitra Mohanty, Pasquale Santangeli, J Tags: ORIGINAL ARTICLE Source Type: research

Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study
Conclusion: Apixaban has similar safety and effectiveness to warfarin for the prevention of cerebral thromboembolism during the periprocedural period of AF ablation.This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - January 13, 2016 Category: Cardiology Authors: TAISHI KUWAHARA, MITSUNORI ABE, MASARU YAMAKI, HIROYUKI FUJIEDA, YUMIKO ABE, KATSUSHI HASHIMOTO, MISAKO ISHIBA, HIROTSUKA SAKAI, KEIICHI HISHIKARI, MASATERU TAKIGAWA, KENJI OKUBO, KATSUMASA TAKAGI, YASUAKI TANAKA, JUN NAKAJIMA, ATSUSHI TAKAHASHI Tags: Original Source Type: research

Targeted Anticoagulation for Atrial Fibrillation Guided by Continuous Rhythm Assessment with an Insertable Cardiac Monitor: The Rhythm Evaluation for Anticoagulation with Continuous Monitoring (REACT.COM) Pilot Study
Conclusions: A targeted strategy of ICM‐guided intermittent NOAC administration is feasible. A large‐scale trial is necessary to evaluate the safety of this approach.This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - October 29, 2015 Category: Cardiology Authors: ROD PASSMAN, PETER LEONG‐SIT, ADIN‐CRISTIAN ANDREI, ANNA HUSKIN, TODD T. TOMSON, RICHARD BERNSTEIN, ETHAN ELLIS, JONATHAN WAKS, PETER ZIMETBAUM Tags: Original Article Source Type: research

Decennial Analysis of Interventional Left Atrial Appendage Closure
Conclusion: During LTFU after LAAC in patients with non‐valvular AF lower event rates than expected are observed for both thrombembolic and bleeding complications This article is protected by copyright. All rights reserved
Source: Journal of Cardiovascular Electrophysiology - April 1, 2015 Category: Cardiology Authors: Boris Schmidt, Stefano Bordignon, Alexander Fuernkranz, Laura Perrotta, Detlef Scherer, KR Julian Chun Tags: Original Article Source Type: research

First Gross Anatomical Description in Human of Left Atrial Appendage Involution after LARIAT Procedure
This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - October 28, 2014 Category: Cardiology Authors: Luis Mora, Faisal Merchant, David B. DeLurgio, Michael H. Hoskins Tags: EP Image Source Type: research

Chronic Kidney Disease Should Not Exclude Patients with Low Atrial Fibrosis from Catheter Ablation Therapy for Atrial Fibrillation
This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - September 26, 2014 Category: Cardiology Authors: LEENHAPONG NAVARAVONG, NAZEM AKOUM Tags: Response to Letter to Editor Source Type: research

Pages: 1  2  3  4